PEOPLE - SpectraSCIENCE makes appointment:
This article was originally published in Clinica
SpectraSCIENCE has named Stephen Blinn executive vice-president. Mr Blinn, who has over 20 years' experience in the medical device sector, joins the US spectrophotometry systems developer from SilverPlatter Education, an electronic medical publishing company.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.